PMID: 698557Aug 19, 1978Paper

HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine

British Medical Journal
R G ChadwickS Sherlock

Abstract

Four patients who had chronic liver disease and were positive for hepatitis B surface antigen (HBsAg) were treated with vidarabine, a synthetic purine nucleoside that inhibits DNA polymerase activity in vitro and in vivo. Before treatment all had raised serum DNA polymerase concentrations. Three also had hepatitis B e (HBe) and were shown by electron microscopy to have hepatitis B virus (Dane) particles in their serum. In all patients 10 days' treatment with vidarabine resulted in an immediate loss of DNA polymerase activity. In three patients the activity returned when treatment was stopped. In those three patients Dane particles and HBe antigen persisted during and after treatment; in the fourth patient, who remained negative for DNA polymerase, HBsAg titres fell. Although vidarabine inhibited virus replication, virus particles did not disappear from the blood in these patients, presumably because the particles were cleared only slowly. Similar results with interferon suggest that the virus disappears, and HBsAg titres fall, some weeks after the fall in DNA polymerase activity. Continued treatment may therefore have a sustained effect on viral replication. Whether vidarabine can permanently clear HBsAg and so arrest chronic l...Continue Reading

References

Oct 1, 1976·Annals of Internal Medicine·S H HindmanJ E Maynard
Jul 1, 1975·The American Journal of the Medical Sciences·W S Robinson

❮ Previous
Next ❯

Citations

Jan 1, 1989·Baillière's Clinical Gastroenterology·G Alexander
Sep 1, 1986·Immunobiology·G Hess, K H Meyer zum Büschenfelde
Dec 1, 1990·Australian and New Zealand Journal of Medicine·K H MakY S Lee
Jan 1, 1986·Antimicrobial Agents and Chemotherapy·M EisenbergT C Merigan
Jan 1, 1980·Clinics in Gastroenterology·P J Jenkins, R Williams
Apr 30, 2014·Expert Opinion on Drug Delivery·Luigi FiumeGiuseppina Di Stefano
Apr 21, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Luigi Fiume, Giuseppina Di Stefano
Sep 1, 1984·The American Journal of Medicine·S M de la MonteG W Moore
Nov 9, 2016·Frontiers in Pharmacology·Shivankar AgrawalSunil K Deshmukh
Nov 1, 1985·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A S LokH C Thomas
Jan 1, 1981·Journal of Medical Virology·A AlbertiG Realdi
Jan 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K HirotaK Okuda
Mar 7, 1983·FEBS Letters·L FiumeA Mattioli
Dec 1, 1984·Journal of the Royal Society of Medicine·D M Novick, H C Thomas
Jun 1, 1980·Acta Pathologica Et Microbiologica Scandinavica. Section B, Microbiology·E NordenfeltE Miller
Mar 1, 1988·Disease-a-month : DM·J A Payne

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.